DMAC DiaMedica Therapeutics Inc.
BEARISH
Impact: 6/10
8-K
8-K Item 2.02: Earnings release
Latest settled — T+20d
DMAC ▼ -13.48% at T+20d
SHORT call ✓ call won +13.48% · α vs SPY +16.61% · entry $6.53 → $5.65
Currently $5.42 · +17.00% from $6.53 entry (call sign-flipped)
T+1d
-3.22%
call +3.22% · α +4.05%
$6.32
settled 5w ago
T+5d
-4.13%
call +4.13% · α +5.64%
$6.26
settled 28d ago
T+20d
-13.48%
call +13.48% · α +16.61%
$5.65
settled 6d ago
T+60d
—
call — · α —
—
in 7w
Price Chart
Loading chart...
Executive Summary
DiaMedica reported Q1 2026 EPS of -$0.19, missing consensus of -$0.17 by 11.8%. Net loss widened to $10.0M from $7.7M a year ago on higher R&D costs, with cash burn increasing. Operating cash flow was -$9.1M vs -$7.1M. No financial guidance was provided.
Actionable Insight
The stock is likely to trade down on the EPS miss and widening losses. Key catalysts remain the ReMEDy2 interim analysis in 4Q 2026 and preeclampsia data readouts; no near-term financial inflection.
Key Facts
- EPS of -$0.19 missed consensus of -$0.17 by 11.8%
- Net loss widened to $10.0M vs $7.7M YoY
- Cash and investments declined to $51.3M from $59.9M at year-end
- Operating cash flow worsened to -$9.1M from -$7.1M
- No revenue or guidance provided
Financial Impact
EPS miss of $0.02 per share; net loss increased 30% YoY
epsnet incomecash burn
Risk Factors
- Continued cash burn exceeding expectations
- Clinical trial delays or negative data
- Dilution risk from future capital raises
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (11 analysts)
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-015218 |
| Document: dmtp20260506_8k.htm | 0001437749-26-015218 |
| Document: 0001437749-26-015218-index-headers.html | 0001437749-26-015218 |
| Document: 0001437749-26-015218-index.html | 0001437749-26-015218 |
| Document: 0001437749-26-015218.txt | 0001437749-26-015218 |
| 8-K Data (Synthetic) | 0001437749-26-015218 |
2 reports for DMAC
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 6, 2026
4w ago
|
8-K
| $6.53 $5.65 | ▲ +13.48% | ▲ +16.61% | $5.42 (+17.00%) |
|
Apr 1, 2026
9w ago
|
DEFA14A
| $6.48 $6.05 | ▼ −6.64% | ▼ −16.51% | $5.42 (−16.36%) |
Showing 2 of 2
US Market Status
Market Closed — Opens Thu (11h 16m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access